...Gonzalo García Fadrique; Daniel Gallego; Domingo Ordaz; Laura Climent Objective: To analyze if there are urodynamic differences in patients with neurogenic detrusor overactivity (NDO) secondary to spinal cord injury (SCI) depending on whether the SCI is complete or incomplete according...

... is needed to identify eventual predictive factors. Multiple sclerosis Incontinence Neurogenic detrusor overactivity Overactive bladder Persistence The second most frequent reason for discontinuation was the prevalence side effects [ 19 ]. The favorable side effect profile of mirabegron...

... from any ideas, methods, instructions or products referred to in the content or advertisements. OnabotulinumtoxinA Botulinum toxin Neurogenic detrusor overactivity Overactive bladder Urinary incontinence Botulinum toxin A (BTA) is frequently used in clinical practice; it's...

..., randomised, prospective study was performed on a total of 23 patients with neurogenic detrusor overactivity. Following randomisation, patients were treated with 300 U of onabotulinumtoxinA (onaBoNT/A) in either the submucosa or the detrusor. Urodynamic examinations were carried out, and a bladder diary...

...H. Schulte-Baukloh; J. Herholz; H. Bigalke; K. Miller; H.H. Knispel Background: Onabotulinumtoxin A (OnaBoNT/A, Botox®) is effective in the treatment of neurogenic detrusor overactivity, however this therapy can fail. In a prospective study, we analyzed patient serum for BoNT/A antibodies (BoNT...

... after about 2 weeks and lasted for about 9 months. Conclusions: Botulinum toxin A treatment in neurogenic detrusor overactivity patients is effective, long-lasting and repeatable. The treatment is minimally invasive and might be considered as an alternative to high-dosage anticholinergic medication. ©...